Nucleic Acid Amplification Testing Market Size, Share & Trends Report

Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2018 - 2025

  • Published Date: Feb, 2017
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-388-1
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 90

Report Overview

The global nucleic acid amplification testing market size was valued at USD 1.78 billion in 2015. Growing demand for advanced diagnostic measures and increasing investments for the development of new biotechnological diagnostic techniques are the key factors propelling the growth of the market. In addition, the growing prevalence of infectious diseases associated with vectors like bacteria & viruses is also fueling the overall growth.

India Nucleic Acid Amplification Testing Market, By Application, 2014 - 2025 (USD Million)

India Nucleic Acid Amplification Test Market size

The global prevalence of communicable diseases remains high despite the presence of various diagnostic and therapeutic techniques in the market. The successful management of an infectious disease is highly dependent on accurate identification of the infecting agent. Nucleic acid amplification provides the most precise detection technique for most of the infectious agents. Thus, it is preferred over traditional diagnostic techniques. In addition, favorable initiatives undertaken by the governments worldwide to introduce these tests in various screening programs are expected to impact the sector positively, especially during the former half of the forecast period.

Along with infectious diseases, NAAT is being extensively studied for applications in other fields like cancer, personalized medicine, and forensics. This is expected to spur the demand for NAAT during the forecast period.

Application Insights

Infectious diseases captured the largest share in 2015 owing to the high usage of NAAT for the detection of disease-causing bacteria and viral agents. The growing emphasis on the management of epidemics, including the most recent one of the Zika virus, is expected to maintain the largest share of the segment throughout the forecast period.

The constantly rising burden of mortality of cancer across the world is catching the attention of healthcare agencies. Thus, high demand for effective early diagnostic methods for various cancer types is anticipated to drive the growth of the segment with a significant CAGR during the forecast period.

Technique Insights

The target amplification system includes PCR technology, which is widely used because of its operational simplicity and high efficiency. Thus, the segment is expected to dominate the nucleic acid amplification testing market throughout the forecast period with the highest CAGR.

Many of the companies had limited access to the PCR techniques until 2006. Because of the limited access, alternative techniques like signal and probe amplification systems were developed. These techniques have applications in selective cases. These techniques are used in place of PCR to minimize the time and money required for diagnosis in cases such as branched DNA probes and anti-DNA-RNA hybrid antibodies.

Global Nucleic Acid Amplification Testing Market, by Technique, 2015

Global Nucleic Acid Amplification Test Market share

Regional Insights

North America dominated the sector with the largest revenue share in 2015. Factors like the presence of a large number of players, a well-developed healthcare system, high disposable income, and favorable reimbursement policies are contributing to high revenue generation in the region.

The Asia Pacific is expected to show the fastest growth from 2016 to 2025, due to presence of fast-growing economies and favorable demographics, such as the high prevalence of infectious diseases, and rising adoption of the advanced diagnostic technologies. The government initiatives to implement NAT in public health services is anticipated to create growth opportunities in the region.

Nucleic Acid Amplification Testing Market Share Insights

This market is highly competitive with a few players capturing most of the share. These companies focus more on new product development to maintain their share. Geographical expansion is of strategic importance to maintain competitiveness. The fast-growing biotechnology space in the Asia Pacific is expected to give rise to the number of local players in the region.

Some of the major players operating in this sector include F. Hoffmann-La Roche Ltd; Becton, Dickinson and Company; Beckman Coulter, Inc.; Abbott Laboratories, Inc.; Illumina, Inc.; Siemens Healthineers; bioMérieux SA; Novartis AG; and Bio-Rad Laboratories, Inc.

Nucleic Acid Amplification Test Market Report Scope

Report Attribute

Details

Market size value in 2020

USD 2.80 billion

Revenue forecast in 2025

USD 4.53 billion

Growth Rate

CAGR of 10.45% from 2016 to 2025

Base year for estimation

2015

Historical data

2014 - 2015

Forecast period

2016 - 2025

Quantitative units

Revenue in USD Million and CAGR from 2016 to 2025

Report coverage

Revenue forecast; company share; competitive landscape; growth factors and trends

Segments covered

Application, technique, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; UK; Germany; India; China; Brazil; Mexico; South Africa

Key companies profiled

F. Hoffmann-La Roche Ltd; Becton, Dickinson and Company; Beckman Coulter, Inc.; Abbott Laboratories, Inc.; Illumina, Inc.; Siemens Healthineers; bioMérieux SA; Novartis AG; Bio-Rad Laboratories, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country; regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the nucleic acid amplification testing market on the basis of application, techniques, and region:

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Infectious Diseases

      • Virus

      • Bacteria

      • Others

    • Cancer

    • Personalized Medicine

    • Genetic and Mitochondrial Disorders

  • Technique Outlook (Revenue, USD Million 2014 - 2025)

    • Target amplification systems

    • Probe amplification systems

    • Signal amplification

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • China

      • India

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

Frequently Asked Questions About This Report

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified